Lewis blood group system in leprosy patients
Autor(a) principal: | |
---|---|
Data de Publicação: | 2000 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Hansenologia Internationalis (Online) |
Texto Completo: | https://periodicos.saude.sp.gov.br/hansenologia/article/view/36433 |
Resumo: | The distribution of Lewis blood group phenotypes in the saliva and on the erythrocytes of leprosy patients were evaluated, Forty seven patients and forty controls were analyzed by means of an agglutination and agglutination inhibition test for the presence of ABH and Lewis antigens on erythrocytes and in the saliva, The frequency of the Lewis phenotypes and secretor and non-secretor phenotypes were determined among the patients and in the control group. The results were: Le(a- b+) =29,8% (62,5%); Le(a+ b-) = 25,5% (7,5%); Le(a- b-) = 44,7% (30,0%); secretor = 59,5% (85%) and non secretor = 40,5% (15%) respectively. Statistical analysis using the X2 test showed significant difference between patients and controls concerning the Lewis phenotype (x2 = 10,46; D,F. = 2; p= 0,005) and secretor phenotype (x2 = 5,64; D.F. = 1; p = 0,018), Using the Z testsignificant differences were found concerning the phenotypes Le (a+ b-) and Le (a- b+) (Z = 2,219; p = 0,027 and Z = 3,058; p = 0,002). The resultsindicate that phenotype Le (a+ b-) is associated with susceptibility to leprosy and secretor phenotype with protection. It is speculated that the presence of Leb' in the saliva inhibits the adherence of M, leprae to the mucosa cells thus protecting against infection. |
id |
ILSL-1_9df87306fc93ffcba19ebec1a187baba |
---|---|
oai_identifier_str |
oai:ojs.periodicos.saude.sp.gov.br:article/36433 |
network_acronym_str |
ILSL-1 |
network_name_str |
Hansenologia Internationalis (Online) |
repository_id_str |
|
spelling |
Lewis blood group system in leprosy patientsSistema sangüíneo Lewis em pacientes hansenianosMycobacterium lepraeFenótipo LewisFenótipo secretorGrupo sanguíneoHanseníaseMycobacterium lepraeLewis phenotypeSecretor phenotypeBlood groupLeprosyThe distribution of Lewis blood group phenotypes in the saliva and on the erythrocytes of leprosy patients were evaluated, Forty seven patients and forty controls were analyzed by means of an agglutination and agglutination inhibition test for the presence of ABH and Lewis antigens on erythrocytes and in the saliva, The frequency of the Lewis phenotypes and secretor and non-secretor phenotypes were determined among the patients and in the control group. The results were: Le(a- b+) =29,8% (62,5%); Le(a+ b-) = 25,5% (7,5%); Le(a- b-) = 44,7% (30,0%); secretor = 59,5% (85%) and non secretor = 40,5% (15%) respectively. Statistical analysis using the X2 test showed significant difference between patients and controls concerning the Lewis phenotype (x2 = 10,46; D,F. = 2; p= 0,005) and secretor phenotype (x2 = 5,64; D.F. = 1; p = 0,018), Using the Z testsignificant differences were found concerning the phenotypes Le (a+ b-) and Le (a- b+) (Z = 2,219; p = 0,027 and Z = 3,058; p = 0,002). The resultsindicate that phenotype Le (a+ b-) is associated with susceptibility to leprosy and secretor phenotype with protection. It is speculated that the presence of Leb' in the saliva inhibits the adherence of M, leprae to the mucosa cells thus protecting against infection.No presente estudo avaliamos a distribuição fenotípica do grupo sanguíneo Lewis na saliva e nos eritrócitos de pacientes hansenianos. Foramanalisados 47 pacientes e 40 indivíduos controles quanto a presença de antígenos ABH bem como dos antígenos Lewis nos eritrócitos e na saliva, pela reação de aglutinação e inibição de aglutinação. As freqüências dos fenótipos Lewis e secretor/não secretor nesses pacientes e no grupo controle foram: Le(a- b+) = 29,8% (62,5%); Le(a+ b-) = 25,5%(7,5%); Le(a- b-) = 44,7% (30,0%); secretor = 59,5% (85%) e não secretor = 40,5% (15%). Em análise do x2 encontramos diferença significativa tanto para o fenótipo Lewis como para o fenótipo secretor, em relação ao grupo controlerespectivamente: x2 = 10,46; GL = 2; p = 0,005 e x2 = 5,64; GL = 1; p = 0,018. Da mesma forma, o teste Z de proporções foi realizado obtendo resultados significativos para os fenótipos Le (a+ b-) e Le (a- b+) , que foram respectivamente: Z = 2,219; p = 0,027 e Z = 3,058; p = 0,002. Osresultados indicam que o fenótipo Le (a+ b-) parece estar associado à suscetibilidade à hanseníase e fenótipo secretor com proteção. Discute-se que a presença de Leb na saliva pode inibir a aderência do M. leprae às células da mucosa, protegendo assim contra infecção.Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo2000-11-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAvaliado pelos paresapplication/pdfhttps://periodicos.saude.sp.gov.br/hansenologia/article/view/3643310.47878/hi.2000.v25.36433Hansenologia Internationalis: leprosy and other infectious diseases; Vol. 25 No. 2 (2000); 115-120Hansenologia Internationalis: hanseníase e outras doenças infecciosas; v. 25 n. 2 (2000); 115-1201982-5161reponame:Hansenologia Internationalis (Online)instname:Instituto Lauro de Souza Lima (ILSL)instacron:ILSLporhttps://periodicos.saude.sp.gov.br/hansenologia/article/view/36433/34711https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Eliane AparecidaRúbio, Eliana MilanesiUra, Somei2023-09-27T14:01:52Zoai:ojs.periodicos.saude.sp.gov.br:article/36433Revistahttps://periodicos.saude.sp.gov.br/hansenologiaPRIhttps://periodicos.saude.sp.gov.br/hansenologia/oaihansen_int@ilsl.br || hansenologia.internationalis@gmail.com || periodicossp@saude.sp.gov.br1982-51610100-3283opendoar:2023-09-27T14:01:52Hansenologia Internationalis (Online) - Instituto Lauro de Souza Lima (ILSL)false |
dc.title.none.fl_str_mv |
Lewis blood group system in leprosy patients Sistema sangüíneo Lewis em pacientes hansenianos |
title |
Lewis blood group system in leprosy patients |
spellingShingle |
Lewis blood group system in leprosy patients Silva, Eliane Aparecida Mycobacterium leprae Fenótipo Lewis Fenótipo secretor Grupo sanguíneo Hanseníase Mycobacterium leprae Lewis phenotype Secretor phenotype Blood group Leprosy |
title_short |
Lewis blood group system in leprosy patients |
title_full |
Lewis blood group system in leprosy patients |
title_fullStr |
Lewis blood group system in leprosy patients |
title_full_unstemmed |
Lewis blood group system in leprosy patients |
title_sort |
Lewis blood group system in leprosy patients |
author |
Silva, Eliane Aparecida |
author_facet |
Silva, Eliane Aparecida Rúbio, Eliana Milanesi Ura, Somei |
author_role |
author |
author2 |
Rúbio, Eliana Milanesi Ura, Somei |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Silva, Eliane Aparecida Rúbio, Eliana Milanesi Ura, Somei |
dc.subject.por.fl_str_mv |
Mycobacterium leprae Fenótipo Lewis Fenótipo secretor Grupo sanguíneo Hanseníase Mycobacterium leprae Lewis phenotype Secretor phenotype Blood group Leprosy |
topic |
Mycobacterium leprae Fenótipo Lewis Fenótipo secretor Grupo sanguíneo Hanseníase Mycobacterium leprae Lewis phenotype Secretor phenotype Blood group Leprosy |
description |
The distribution of Lewis blood group phenotypes in the saliva and on the erythrocytes of leprosy patients were evaluated, Forty seven patients and forty controls were analyzed by means of an agglutination and agglutination inhibition test for the presence of ABH and Lewis antigens on erythrocytes and in the saliva, The frequency of the Lewis phenotypes and secretor and non-secretor phenotypes were determined among the patients and in the control group. The results were: Le(a- b+) =29,8% (62,5%); Le(a+ b-) = 25,5% (7,5%); Le(a- b-) = 44,7% (30,0%); secretor = 59,5% (85%) and non secretor = 40,5% (15%) respectively. Statistical analysis using the X2 test showed significant difference between patients and controls concerning the Lewis phenotype (x2 = 10,46; D,F. = 2; p= 0,005) and secretor phenotype (x2 = 5,64; D.F. = 1; p = 0,018), Using the Z testsignificant differences were found concerning the phenotypes Le (a+ b-) and Le (a- b+) (Z = 2,219; p = 0,027 and Z = 3,058; p = 0,002). The resultsindicate that phenotype Le (a+ b-) is associated with susceptibility to leprosy and secretor phenotype with protection. It is speculated that the presence of Leb' in the saliva inhibits the adherence of M, leprae to the mucosa cells thus protecting against infection. |
publishDate |
2000 |
dc.date.none.fl_str_mv |
2000-11-30 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Avaliado pelos pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/36433 10.47878/hi.2000.v25.36433 |
url |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/36433 |
identifier_str_mv |
10.47878/hi.2000.v25.36433 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://periodicos.saude.sp.gov.br/hansenologia/article/view/36433/34711 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo |
publisher.none.fl_str_mv |
Instituto Lauro de Souza Lima da Secretaria de Estado da Saúde de São Paulo |
dc.source.none.fl_str_mv |
Hansenologia Internationalis: leprosy and other infectious diseases; Vol. 25 No. 2 (2000); 115-120 Hansenologia Internationalis: hanseníase e outras doenças infecciosas; v. 25 n. 2 (2000); 115-120 1982-5161 reponame:Hansenologia Internationalis (Online) instname:Instituto Lauro de Souza Lima (ILSL) instacron:ILSL |
instname_str |
Instituto Lauro de Souza Lima (ILSL) |
instacron_str |
ILSL |
institution |
ILSL |
reponame_str |
Hansenologia Internationalis (Online) |
collection |
Hansenologia Internationalis (Online) |
repository.name.fl_str_mv |
Hansenologia Internationalis (Online) - Instituto Lauro de Souza Lima (ILSL) |
repository.mail.fl_str_mv |
hansen_int@ilsl.br || hansenologia.internationalis@gmail.com || periodicossp@saude.sp.gov.br |
_version_ |
1796797581417775104 |